Hiscox PLC
21 October 2002
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE
UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR THE REPUBLIC OF IRELAND
FOR IMMEDIATE RELEASE 21 October 2002
HISCOX PLC
Provisional announcement of Rights Issue take-up
The board of Hiscox announces that, by 10.30 a.m. today, being the latest time
and date for acceptance and payment in full under the Rights Issue, the
provisional level of acceptances received by the Company (subject to final
confirmation that such acceptances are valid in accordance with the terms of the
Prospectus) represented approximately 62.7 per cent. of the New Ordinary Shares
offered pursuant to the Rights Issue.
This provisional level of acceptance did not include any acceptance by Chubb
Investment Services Limited ('Chubb'), no acceptance from which had been
received by 10.30 a.m. today. Chubb's entitlement under the Rights Issue
amounted to approximately 28.3 per cent. of the New Ordinary Shares being
offered. It is expected that, as a consequence of Chubb not taking up its
entitlement, its holding in Hiscox will fall from 28.3 per cent. of the issued
share capital of the Company to 18.9 per cent.
A further announcement will be made in due course, detailing the final take-up
of the Rights Issue.
Terms in this press release bear the same meaning, unless otherwise required by
the context, as defined in the prospectus published by Hiscox on 10 September
2002.
Enquiries
Hiscox plc Bronek Masojada 020 7448 6000
Stuart Bridges
ING Barings Paul Newman 020 7767 1000
Simon Edwards
NM Rothschild Philip Swatman 020 7280 5000
Jonathan Eddis
The Maitland Consultancy Suzanne Bartch 020 7379 5151
Philip Gawith
ING Barings and NM Rothschild are acting for the Company, and no one else, in
connection with the Rights Issue and will not be responsible to any other person
for providing the protections afforded to their respective clients or for
providing advice in relation to the proposed Rights Issue.
This announcement does not constitute or form part of, and should not be
construed as, an offer for sale or subscription of, or solicitation of an offer
to buy or subscribe for, any securities of Hiscox plc nor should it, or any part
of it, form the basis of, or be relied on in connection with any contract or
commitment whatsoever. Any decision in connection with the Rights Issue should
be made solely on the basis of the information contained in the Prospectus.
This announcement is not for publication or distribution or release, directly or
indirectly, in the United States, Canada, Japan, Australia, South Africa or the
Republic of Ireland. This announcement does not constitute or form any part of
any offer to sell, issue or to acquire any securities of the Company in the
United States, Canada, Japan, Australia, South Africa, the Republic of Ireland
or in any other jurisdiction. Neither the Company's New Ordinary Shares, Fully
Paid Rights nor the Provisional Allotment Letters are being or will be
registered under the US Securities Act of 1933, as amended (the 'Securities
Act') and may not be offered or sold in the United States (as such term is
defined in Regulation S under the Securities Act) at any time except pursuant to
the terms of an applicable exemption under the Securities Act and applicable
securities laws of the states of the United States.
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.